Traditional and social media efforts are paying off.

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...

With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...